Philippines IHR Policies - Antimicrobial Resistance

Antimicrobial Resistance

Antimicrobial resistance - National policies

Pres AO 2014-42-Creating an inter-agency committee for the formulation of a national plan to combat antimicrobial resistance in the Philippines-10Apr2014

Antimicrobial Resistance Surveillance Program (ARSP) annual reports

2018 ARSP annual report summary - version2 2019 ARSP annual report summary - v1-1 2020 ARSP annual report summary 2021 ARSP annual report summary 2022 ARSP annual report summary

Combat antimicrobial resistance plans

DOH DA DOST DTI DILG. Philippine National Action Plan to Combat Antimicrobial Resistance: One Health Approach - 2014 DOH DA DOST DTI DILG. Philippine National Action Plan to Combat Antimicrobial Resistance: One Health Approach - 2019-2023

Other policy issuances by government agencies

DOH ao2015-0049-Rules and Regulations Governing the Antimicrobial Resistance Surveillance Program Accreditation of Bacteriology Laboratories in the Philippines for the PhilHealth Reimbursement of Select Antibiotics in the Philippine National Drug Formulary-23Nov2015DOH ao2015-0049-A - Amendment to AO 2015-0049 entitled "Rules and Regulations Governing the Antimicrobial Resistance Surveillance Program Accreditation of Bacteriology Laboratories in the Philippines for the PhilHealth Reimbursement of Select Antibiotics in the Philippine National Drug Formulary-18May2017 DOH ao2022-0051-Revised national policy on Infection Prevention and Control in all public and private health facilities-9Dec2023 DOH ao2023-0011-Implementing guidelines for the Antimicrobial Stewardship (AMS) Program for primary care facilities-7Jul2023 DOH dc2023-0314-Conduct of the 2023 Antimicrobial Stewardship (AMS) Blended Learning Framework Program for Primary Health Care (PHC) facilities through online platform-10Jul2023 DOH dc2023-0522 2023 National Dissemination Forum of the Antimicrobial Use - Point Prevalence Survey in the Philippines-5Oct2023 DOH dm2021-0127-Designation of select hospitals as the training hubs for the implementation of the Antimicrobial Stewardship (AMS) Blended Learning Program Framework for Hospitals-9Mar2021 DOH dm2022-0043-Rational use of antimicrobial agents and investigational drugs for the management of COVID-19-20Jan2022 DOH DA JAO 2013-0026-Rules on the regulation of veterinary drugs and products, veterinary biological products, and veterinary drug establishments-13Sep2013 DOH. National Antibiotic Guidelines - 2018 FDA Advisory 2012-017-Antimicrobial resistance-29Nov2012 NMIS Memo CO-2024-02-029-Collection and submission of samples for pathogens monitoring, on-site environmental hygiene monitoring and antimicrobial resistance surveillance program-31Jan2024 PHIC circ2018-0009-Use of restricted antimicrobials in PhilHealth-accredited health care institutions in accordance with the requirements of the Antimicrobial Resistance Surveillance Program (ARSP)- 2018

Page updated

Google Sites

Report abuse